scholarly article | Q13442814 |
P356 | DOI | 10.1002/14651858.CD008012.PUB2 |
P8608 | Fatcat ID | release_zoylrkzs2jccjdl5rkcnwylqja |
P50 | author | Jürgen Bengel | Q61737626 |
P2093 | author name string | Harald Baumeister | |
Nico Hutter | |||
P2860 | cites work | Antidepressants for depressed elderly | Q24244664 |
Drugs versus placebo for dysthymia | Q24246945 | ||
Psychological interventions for coronary heart disease | Q24247124 | ||
Active placebos versus antidepressants for depression | Q24247474 | ||
Coronary heart disease and depression: a review of recent mechanistic research | Q33266570 | ||
Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction | Q33917874 | ||
Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology | Q33996248 | ||
Prevalence of depression in survivors of acute myocardial infarction. | Q34704102 | ||
Epidemiology of comorbid coronary artery disease and depression | Q35189634 | ||
Depression and cardiovascular disease: mechanisms of interaction | Q35189643 | ||
Mental disorders among persons with heart disease - results from World Mental Health surveys | Q36102964 | ||
Psychiatric and somatic comorbidities are negatively associated with quality of life in physically ill patients | Q36285573 | ||
Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial | Q38400118 | ||
Increased 12-month prevalence rates of mental disorders in patients with chronic somatic diseases | Q40167091 | ||
Mental disorders in patients with obesity in comparison with healthy probands | Q40247057 | ||
Depression following myocardial infarction: first-ever versus ongoing and recurrent episodes | Q40374824 | ||
The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment | Q40850649 | ||
Depression and other psychological risks following myocardial infarction | Q43732173 | ||
Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial | Q44482199 | ||
Assessment and treatment of depression in patients with cardiovascular disease: National Heart, Lung, and Blood Institute working group report. | Q51912565 | ||
New Onset Depression Following Myocardial Infarction Predicts Cardiac Mortality | Q56827570 | ||
Depression and Coronary Heart Disease | Q56928538 | ||
Depression as a Risk Factor for Mortality in Patients With Coronary Heart Disease: A Meta-analysis | Q60450618 | ||
Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction | Q73935042 | ||
Depression and health-care costs during the first year following myocardial infarction | Q73954779 | ||
P921 | main subject | pharmacology | Q128406 |
coronary artery disease | Q844935 | ||
P577 | publication date | 2010-07-07 | |
P1433 | published in | Cochrane Database of Systematic Reviews | Q15750361 |
P1476 | title | Psychological and pharmacological interventions for depression in patients with coronary artery disease |
Search more.